Visit our service page:

Welcome to Pioneer Research

A biopharmaceutical company dedicated to discovering and developing tomorrow’s therapeutic strategies

Latest news

  • Pioneer Research receives Innovation Norway funding

    In March 2024, Pioneer Research was awarded 200 000 NOK in “Oppstartstilskudd” from Innovation Norway. The funding will be used to conduct marked analyses, further develop our services and recruit pilot customers in the first quarter of 2024.

  • Pioneer Research Granted Tekna Stipend

    In the fall of 2023, Pioneer Research was granted the Harald Boes kompetansestipend from Tekna Oslo for the development of the miP Cancer Target Discovery Plattform. The project will be conducted throughout 2024 with our collaborators at the University of Oslo.

  • Pioneer Research Awarded 2M NOK from the Norwegian Cancer Society

    At the end of December 2022, Marie Rogne and Pioneer Research received the amazing news that she was one out of five recipients, among 69 applicants, to receive the grant for the innovative and exciting new posting “Pioneer Projects” by The Norwegian Cancer Society. This was the first year companies were allowed to apply and we are therefor extra grateful to be picked out as one of the recipients. The 2M NOK funding will be used for our “high-risk/high-reward” project of looking at targeted inhibition of transcription factors by microProteins in treatment resistant cancer.

    Read the article posted by the Norwegian Cancer Society here:

    Foto: Jorunn Valle Nilsen
  • Pioneer Research Awarded Regional Funding

    In October of 2022, Pioneer Research was granted regional funding from Oslo Innovation District for their project “Transcription Factor regulators for resistant and untreatable cancer”. The project will be conducted in the later half of 2022 in collaboration with Philippe Collas group at IMB, University of Oslo.

Partners & Funders

Supporters and Partners